Figure 2From: Protease inhibitor associated mutations compromise the efficacy of therapy in human immunodeficiency virus – 1 (HIV-1) infected pediatric patients: a cross-sectional studyPresence of drug-specific HIV-1 mutations in relation to ARV regimens.Back to article page